Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementia.

The need for end-of-life care is going to increase substantially in many countries in the coming decades. In addition to considering the effectiveness of such care, it is also vital, given resource scarcity, to assess its costs and cost-effectiveness. Costs include the direct care inputs, other related services, and indirect costs, such as lost employment. These need to be measured in an appropriate way, and one relevant questionnaire is the Client Service Receipt Inventory. Studies of multiple sclerosis, Parkinson's disease, and dementia that have used this questionnaire are described in this article. What is clear is that the costs of providing end-of-life care can be high and that informal care from family members and friends accounts for a substantial amount of the overall costs.

[1]  C. Ritchie,et al.  A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia , 2005, International Psychogeriatrics.

[2]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[3]  Sube Banerjee,et al.  Formal and informal care for people with dementia: variations in costs over time , 2003, Ageing and Society.

[4]  I. Higginson,et al.  Dying with cancer, living well with advanced cancer. , 2008, European journal of cancer.

[5]  D. Burn,et al.  Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  A. Thompson,et al.  Multiple sclerosis in the UK: service use, costs, quality of life and disability. , 2008, PharmacoEconomics.

[7]  P. Bath,et al.  Economic evaluation of specialist cancer and palliative nursing: a literature review. , 2003, International journal of palliative nursing.

[8]  I. Higginson,et al.  Improving generalist end of life care: national consultation with practitioners, commissioners, academics, and service user groups , 2008, BMJ : British Medical Journal.

[9]  Paul McCrone,et al.  Predicting the cost of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[10]  A. Edwards,et al.  Do hospital-based palliative teams improve care for patients or families at the end of life? , 2002, Journal of pain and symptom management.

[11]  M A Koopmanschap,et al.  Towards a new approach for estimating indirect costs of disease. , 1992, Social science & medicine.

[12]  C. Brewin,et al.  Measuring mental health needs , 1992 .

[13]  T. Burns Measuring Mental Health Needs (2nd edn) , 2003, British Journal of Psychiatry.

[14]  K. Davis,et al.  The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease , 1997, International journal of geriatric psychiatry.

[15]  I. Higginson,et al.  Where people die (1974—2030): past trends, future projections and implications for care , 2008, Palliative medicine.

[16]  Martin Knapp,et al.  Costing psychiatric interventions. , 1992 .

[17]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.